BACKGROUND: The cardiac implications of obesity in kidney transplant recipients are not well-described. METHODS: We examined associations of body mass index (BMI) at transplant with posttransplant cardiac risk among 1102 renal allograft recipients at a single center in 1991 to 2004. Cumulative posttransplant incidences of congestive heart failure (CHF), atrial fibrillation (AF), myocardial infarction, and a composite of these cardiac diagnoses were estimated by the Kaplan-Meier method. Bivariate (hazards ratio) and covariate (adjusted hazards ratio) relationships of BMI increments with cardiac risk were modeled by Cox's regression. We also systematically reviewed the literature on BMI and cardiac events after transplant. RESULTS: In the local data, 5-year cumulative incidence of any cardiac diagnosis rose from 8.67% to 29.35% across the lowest to highest BMI quartiles (P=0.02), driven primarily by increases in CHF and AF. In contrast, the rate of myocardial infarction did not differ by BMI quartile (P=0.56). Each 5 U BMI increase predicted 25% higher risk of the cardiac composite (hazards ratio 1.25, 95% CI 1.07-1.47, P=0.005), a relationship that persisted with significance after covariate adjustment (adjusted hazards ratio 1.19, 95% CI 1.00-1.43, P=0.049). BMI independently predicted cardiac risk in subcohorts with pretransplant heart disease and with nondiabetic renal failure. Data from 26 original articles support BMI as a risk factor for posttransplant CHF and AF, whereas findings for coronary/ischemic outcomes are inconsistent and predominantly negative. CONCLUSIONS: High BMI at transplant predicts increased cardiac risk, especially of CHF and AF. Further research should examine whether obesity treatment modifies cardiac risk after kidney transplantation.
BACKGROUND: The cardiac implications of obesity in kidney transplant recipients are not well-described. METHODS: We examined associations of body mass index (BMI) at transplant with posttransplant cardiac risk among 1102 renal allograft recipients at a single center in 1991 to 2004. Cumulative posttransplant incidences of congestive heart failure (CHF), atrial fibrillation (AF), myocardial infarction, and a composite of these cardiac diagnoses were estimated by the Kaplan-Meier method. Bivariate (hazards ratio) and covariate (adjusted hazards ratio) relationships of BMI increments with cardiac risk were modeled by Cox's regression. We also systematically reviewed the literature on BMI and cardiac events after transplant. RESULTS: In the local data, 5-year cumulative incidence of any cardiac diagnosis rose from 8.67% to 29.35% across the lowest to highest BMI quartiles (P=0.02), driven primarily by increases in CHF and AF. In contrast, the rate of myocardial infarction did not differ by BMI quartile (P=0.56). Each 5 U BMI increase predicted 25% higher risk of the cardiac composite (hazards ratio 1.25, 95% CI 1.07-1.47, P=0.005), a relationship that persisted with significance after covariate adjustment (adjusted hazards ratio 1.19, 95% CI 1.00-1.43, P=0.049). BMI independently predicted cardiac risk in subcohorts with pretransplant heart disease and with nondiabetic renal failure. Data from 26 original articles support BMI as a risk factor for posttransplant CHF and AF, whereas findings for coronary/ischemic outcomes are inconsistent and predominantly negative. CONCLUSIONS: High BMI at transplant predicts increased cardiac risk, especially of CHF and AF. Further research should examine whether obesity treatment modifies cardiac risk after kidney transplantation.
Authors: Bertram L Kasiske; Charles B Cangro; Sundaram Hariharan; Dondald E Hricik; Ronald H Kerman; David Roth; David N Rush; Miguel A Vazquez; Matthew R Weir Journal: Am J Transplant Date: 2001 Impact factor: 8.086
Authors: Kevin C Abbott; Iman O Hypolite; Paul Hshieh; David Cruess; Allen J Taylor; Lawrence Y Agodoa Journal: Ann Epidemiol Date: 2002-02 Impact factor: 3.797
Authors: H U Meier-Kriesche; M Vaghela; R Thambuganipalle; G Friedman; M Jacobs; B Kaplan Journal: Transplantation Date: 1999-11-15 Impact factor: 4.939
Authors: Richard J Howard; Van B Thai; Pamela R Patton; Alan W Hemming; Alan I Reed; Willem J Van der Werf; Shiro Fujita; Janet L Karlix; Juan C Scornik Journal: Transplantation Date: 2002-01-15 Impact factor: 4.939
Authors: J L Gore; P T Pham; G M Danovitch; A H Wilkinson; J T Rosenthal; G S Lipshutz; J S Singer Journal: Am J Transplant Date: 2006-02 Impact factor: 8.086
Authors: Satish Kenchaiah; Jane C Evans; Daniel Levy; Peter W F Wilson; Emelia J Benjamin; Martin G Larson; William B Kannel; Ramachandran S Vasan Journal: N Engl J Med Date: 2002-08-01 Impact factor: 91.245
Authors: M Z Molnar; E Streja; C P Kovesdy; S Bunnapradist; M S Sampaio; J Jing; M Krishnan; A R Nissenson; G M Danovitch; K Kalantar-Zadeh Journal: Am J Transplant Date: 2011-04 Impact factor: 8.086
Authors: Elani Streja; Miklos Z Molnar; Csaba P Kovesdy; Suphamai Bunnapradist; Jennie Jing; Allen R Nissenson; Istvan Mucsi; Gabriel M Danovitch; Kamyar Kalantar-Zadeh Journal: Clin J Am Soc Nephrol Date: 2011-03-17 Impact factor: 8.237
Authors: Patrick M Ercole; Paula M Buchanan; Krista L Lentine; Thomas E Burroughs; Mark A Schnitzler; Kian A Modanlou Journal: J Nephrol Ther Date: 2012-01-18
Authors: Krista L Lentine; Huiling Xiao; Daniel C Brennan; Mark A Schnitzler; Todd C Villines; Kevin C Abbott; David Axelrod; Jon J Snyder; Paul J Hauptman Journal: Am Heart J Date: 2009-12 Impact factor: 4.749